EV/EBITDA
0.30
0.000.00%
Fri, 29 Nov 2024 21:49:33 GMT
Summary:
Oncternal Therapeutics EV/EBITDA is currently 0.30, unchanged from the previous trading day. Over the past year, it has increased by +0.45 (+300.00%). ONCT EV/EBITDA is now -97.46% below its all-time high of 11.81.ONCT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +30.4% |
| 3 m3 months | +287.5% |
| 6 m6 months | +155.6% |
| ytdytd | +149.2% |
| 1 y1 year | +300.0% |
| 5 y5 years | +109.5% |
ONCT EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.30 | at high | 0.22 | +36.4% |
| 3 m | 3 months | 0.30 | at high | -0.16 | +287.5% |
| 6 m | 6 months | 0.30 | at high | -0.55 | +154.6% |
| 1 y | 1 year | 0.30 | at high | -0.62 | +148.4% |
| 3 y | 3 years | 1.35 | -77.8% | -1.91 | +115.7% |
| 5 y | 5 years | 1.35 | -77.8% | -18.80 | +101.6% |
| alltime | all time | 11.81 | -97.5% | -21.68 | +101.4% |
Oncternal Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 0.30(-149.2%) |
| 2023 | -0.61(+35.6%) |
| 2022 | -0.45(-34.8%) |
| 2021 | -0.69(-90.1%) |
| 2020 | -6.98(+217.3%) |
| 2019 | -2.20(-1016.7%) |
| 2018 | 0.24(-102.8%) |
| 2017 | -8.43(+190.7%) |
| 2016 | -2.90(-24.9%) |
| 2015 | -3.86(+38.4%) |
| Date | Value |
|---|---|
| 2014 | -2.79(+34.8%) |
| 2013 | -2.07(-53.1%) |
| 2012 | -4.41(+6.0%) |
| 2011 | -4.16(-188.1%) |
| 2010 | 4.72(-288.0%) |
| 2009 | -2.51(-77.8%) |
| 2008 | -11.29(+9.7%) |
| 2007 | -10.29(-21.1%) |
| 2006 | -13.04(+214.2%) |
| 2005 | -4.15(-64.2%) |
| 2004 | -11.59 |
FAQ
- What is Oncternal Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Oncternal Therapeutics?
- What is ONCT EV/EBITDA year-to-date change?
- What is Oncternal Therapeutics EV/EBITDA year-on-year change?
What is Oncternal Therapeutics EV/EBITDA?
The current EV/EBITDA of ONCT is 0.30
What is the all time high EV/EBITDA for Oncternal Therapeutics?
Oncternal Therapeutics all-time high EV/EBITDA is 11.81
What is ONCT EV/EBITDA year-to-date change?
Oncternal Therapeutics EV/EBITDA has changed by +0.91 (+149.18%) since the beginning of the year
What is Oncternal Therapeutics EV/EBITDA year-on-year change?
Over the past year, ONCT EV/EBITDA has changed by +0.45 (+300.00%)